On weak day for biotech stocks, ImmunoGen slides on setbacks for 2 experimental drugs
April 27, 2015 at 15:02 PM EDT
Shares of cancer drugmaker ImmunoGen slumped Monday as Wall Street digested two hits to the company's drug development pipeline.
